Anthony Caggiano - 03 Feb 2023 Form 4 Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role
Chief Medical Officer
Signature
/s/ Anthony Caggiano
Issuer symbol
CGTX
Transactions as of
03 Feb 2023
Transactions value $
$0
Form type
4
Filing time
07 Feb 2023, 15:05:40 UTC
Previous filing
25 Mar 2022
Next filing
09 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGTX Common Stock Award $0 +94,406 $0 94,406 03 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGTX Stock Option (Right to Buy) Award $0 +94,406 $0 94,406 03 Feb 2023 Common Stock 94,406 $2.12 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
F2 The option vests 33.3% on February 3, 2024, with the remaining 66.7% vesting in 24 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates.